Peer Review History
Original SubmissionJuly 22, 2020 |
---|
PONE-D-20-22771 Trends and predictors of in-hospital mortality among babies with hypoxic ischaemic encephalopathy at a tertiary hospital in Nigeria: A retrospective cohort study PLOS ONE Dear Dr. Ezenwa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 29 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Ju Lee Oei Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2.) Thank you for stating the following in the Acknowledgments Section of your manuscript: 'GO is funded by the Glaxo Smith Kline/ Sub-Saharan Africa Consortium for Advanced Biostatistics training/DELTAS Africa Fellowship through the School of Public Health, University of Witwatersrand. The views expressed are those of the authors and not necessarily that of the funders.' We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 'The authors received no specific funding for this work' Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: - The research article has some implications for providing trends of neonatal encephalopathy/HIE in Nigeria. But there is no demarcation described if the cases were NE or HIE. - The predictors of outcome need much more elaboration- in terms of the maternal morbidities, the individual criteria used to diagnose encephalopathy, the number of neonates without adequate resuscitation, post-natal level of supportive care provided, the cause of death in mild HIE neonates etc. - Some of the statistical analysis methods have questionable significance (specific queries are attached in the manuscript). Statistical charts/graphs could not be assessed. - Severity of HIE described in detail as one of the predictor of fatality self-implies with more fatality and does not add much information to current literature. The mortalities in mild HIE cases need more explanation, what is authors comment on the accuracy of neurological assessments made at the time of admission and with respect to age of the neonate. Diagnosing mild HIE beyond 48 hours could also indicate the recovery state of moderate-to severe encephalopathy.. However, the research of any kind in this field in Nigeria will have implications in promoting better care of neonates with birth asphyxia. Reviewer #2: Ezennwa et. al presented results with discussion of temporal trend analysis and retrospective cohort study over a 5-year period of asphyxiated neonates admitted to the neonatal unit of a Nigerian Hospital. Among their major findings were a median age at admission of 26.5 hours, male to female ration of 2.1:1, and 84% outworn status. Prevalence and fatality rates respectively for HIE were 7.1% and 25.3%, with fluctuating incidence over the 5 years studied. The results presented underscore the need for worldwide concerns for mortality and morbidity as a result of hypoxic-ischemic brain injuries, particularly in developing countries. The authors correctly emphasize the importance of improved obstetrical practices and resuscitative interventions. However, they need to expand their discussion section and include for the readership the distal and proximal risk factors that impact the success of these practices and later expression of neonatal encephalopathy (NE) with neurologic sequelae (ACOG Task Force, revised 2019). The authors need to address the diagnostic analyses that integrate maternal placental and fetal conditions affecting the triad with neonatal factors expressed as NE. Placental diseases have been grouped within the great obstetrical syndromes (DiRenzo 2009, Brosens 2011)(eg. preeclampsia, fetal growth restriction, prematurity and placental accreta spectrum) based on first-trimester abnormal placentation resulting either in chronic placental diseases (ie malperfusion syndromes) or acute intrapartum events such as abruptio placenta (Ananth 2010). Dual horizontal and vertical diagnostic analyses allow the diagnostician to evaluate the triad as a maturing phenotype across three trimesters, expressing adaptive or maladaptive systems-biological mechanisms that preserve fetal health or promote disease (Scher 2019). Intrapartum HIE is in fact uncommon exclusively, and when it occurs more likely in association with antepartum more than intrpartum brain injury because of chronic placental diseases (Turner, 2020), given the loss of the peripheral chemoreflex (Lear 2018). Inflammatory diseases play a large role in the expression of prematurity as well as NE. Mimicry of intrapartum HIE may in fact be inflammatory responses on the maternal or fetal surfaces of the placenta causing both asphyxia and inflammatory mediator injuries before and during labor and delivery (Scher 2020). This is a major factor that suggests why therapeutic hypothermia is effective in only 1 out of 8 neonates (McIntyre 2015). Lack of medical equity and misassignment to lower levels of maternal care because of a lack of adequate fetal surveillance contribute to adverse outcomes. This is particularly experienced in developing countries, although health disparities exist in the most developed nations! This expanded discussion may help with future research efforts by these authors if more MPF triad data and placental findings can be analyzed and reported from their hospital. They should be commended for their efforts given how concerning trimester-specific causes of fetal brain injuries result in costly human and economic consequences. Reviewer #3: Hypoxic ischaemic encephalopathy (HIE) is the second cause of neonatal mortality worldwide and the first in many settings in Africa. This manuscript addresses one of the most causes of preventable deaths in neonates. Nigeria has among the largest number of neonatal deaths due to hypoxic ischaemic encephalopathy and has started a program to reduce preventable neonatal deaths. This manuscript is a report of a retrospective study of a hospital based study. The study was conducted in Lagos University Teaching Hospital (LUTH) from 1 January 2015 to 31st December, 2019. LUTH is one of the three publicly funded tertiary health institutions in Lagos, South-Western Nigeria and has a very large NICU (80 cots). I find two major problems. 1) The data on prevalence is confusing as this is a hospital-based study. It should be clearly stated in the Methods. Most importantly, in the Discussion, the authors must be very careful when comparing data on prevalence or incidence of HIE as some studies are population-based but others are hospital-based. Similarly, case fatality rate depends on the population selected. 2) There should be a careful selection of the references with more focus on critically addressing references of international interest from high impact journals rather than local or selected experiences/reports or non-peer-reviewed reviews. Introduction The Introduction is too long and not focused. Important references from higher impact journals are missing. Many of the references are non-peer-reviewed, local, or just not the best on the subject. A thorough review of the literature to address the high level of publications on the contribution of HIE to neurodevelopmental outcomes and the prevention or immediate treatment is needed. Methods The Methods are well-described but they should emphasize that this is a hospital-based study. It is obvious but it is important to address it as a population-based study would be ideal but not realistic. There are referral biases so the incidence is calculated per neonatal admission. The Discussion should address this better. It is not stated how was HIE defined. The Sarnat and Sarnat exam is mentioned but this exam cannot rule out other encephalopathies. This is a hospital-based study but referral patterns and potential changes over time are not addressed. Was therapeutic hypothermia used? Results It would be important to know the unbooked rate of the inborn babies admitted for non HIE reasons to see unbooked is related to HIE. Some results are reported with two decimal points; one is sufficient. Table 2 which addresses inborn infants has one row of data on outborn deliveries. Figures 1a and 1b are not necessary. The colors and font size selection of Figure 3 make the figure difficult to read and understand the data. Table 4 should include the N for each of the two columns on the top but if the N varies, then it should be per cell. It is important to use terms that describe associations rather than causality. Terms such as “influence” for example in “Babies’s gender, maternal age and mode of delivery did not influence the hazard of death among the babies (Table 5)” should not be used. Discussion This study has many limitations which should be addressed but most importantly, interpret the results based on those limitation. First paragraph. Similarly, “prediction” should not be used as the sample size is rather small tom perform prediction studies and the authors have not done this. The study describes associations so related terms are acceptable but prediction is not. The discussion on prevalence is quite confusing as rates are reported by population based in some studies and by hospital admissions in others. This is like comparing apples and oranges. Rather than provide two references of when resuscitation training and neonatal care “increased markedly” in Nigeria (around 2010, which is unrelated to this study’s time frame), the authors should reference the evidence that support each of these interventions to prevent HIE. The Discussion needs to be focused. Minor comments APGAR is misspelled. The correct spelling is Apgar. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Mark S Scher Reviewer #3: Yes: Waldemar A Carlo [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
Revision 1 |
PONE-D-20-22771R1 Trends and predictors of in-hospital mortality among babies with hypoxic ischaemic encephalopathy at a tertiary hospital in Nigeria: A retrospective cohort study PLOS ONE Dear Dr. Ezenwa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please address the comments of both reviewers, particular those from reviewer #3. Please submit your revised manuscript by Apr 17 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Ju Lee Oei Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: As stated for my initial review, this is an important hospital-based study that attempts to address important and complex factors influencing neonatal morbidity (and maternal mortalities!), still more profoundly expressed in resource-poor nations! Thank-you to the authors for incorporating Reviewer 2's suggestions. Other than proofing the manuscript for occasional word corrections in tense, etc in several instances (e.g. line 48,) , this revised manuscript is acceptable for publication. The challenges for my colleagues who present their research findings regarding maternal- child care before and after birth need constant scrutiny and attention through peer-reviewed dialogue to achieve world-wide medical equity. These challenges existed during the latter part of the 20th century following WWII and were addressed by nations with adequate research and public health resources to reduce mortalities and improve morbidities in their nations (e.g. Collaborative Perinatal Project in the US). Despite obvious successes based on these birth cohort efforts, new challenges have either replaced or sustained the former ones given lack of resources even within these nations. Partnerships among healthcare, social-support agencies and government are needed to merge priorities that will ultimately improve both medical and socioeconomic health for an entire nation's citizenry. Good luck for future contributions. Reviewer #3: General comments This is a hospital-based study largely of a subpopulation of referred infants with HIE in a large city where there are other hospitals receiving referred infants. The observed trends and changes over time could be due to referral bias. This is now addressed well in the Discussion but not in the Abstract (especially in the Conclusions). Abstract The abstract needs to address the potential for referral bias. This is a hospital-based study conducted retrospectively and covering many years. The authors must be more careful when addressing the incidence and fatality rate of asphyxia and refer to hospital admissions rather than make general unqualified statements such as “The annual incidence declined by 1.4% per annum while the annual fatality rate increased by 10.3% per annum from 2015 to 2019.” About four fifths of the admissions with HIE were outborn babies. Their mortality rate was four-fold that of inborn babies. The referral bias for mortality if also extremely important. Introduction The Introduction is based on rather low level of evidence studies and reviews rather than strong data on HIE from well designed RCTs, cohort studies, and meta-analyses. This was commented in the previous review but not addressed. There are major studies from multi-country (LMICs) populations as well as some single country (LMIC) that should addressed as well as the meta-analysis rather than report small retrospective cohorts. Methods There are referral biases so the incidence is calculated per neonatal admission. The Methods and Discussion must address this well. Were there changes in referral patterns? Did the proportion of admitted babies compared to other 2 NICUs in Lagos differ? I think the best solution is to acknowledge in both the Methods and Discussion (including the Conclusions) that referral bias was possible. If it can be quantified, it would be best, but it is understood that this may be hard to quantify. The statistical analysis must be carefully performed as referral bias can have a big impact. Results It would be best to compare inborn and outborn infants in Tables 1 and 2. Figures 1a and 1b are not needed. Fig 1a does not have the n/N data that should be provided better in the text. A three d pie does not help. Discussion This study has many limitations which should be addressed but most importantly, interpret the results based on those limitations. The Conclusions miss the point totally. Minor HIE and asphyxia (e.g. Figures 2a and 2c) are used. It is best to stick to one only. The title of Figure 2c has a typo (severtly). ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Mark Steven Scher MD Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
Trends and predictors of in-hospital mortality among babies with hypoxic ischaemic encephalopathy at a tertiary hospital in Nigeria: A retrospective cohort study PONE-D-20-22771R2 Dear Dr. Ezenwa, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ju Lee Oei Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: I find this second revision has been thorough and addresses my major concerns well. The authors have fulfilled all the editing requirements. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: No |
Formally Accepted |
PONE-D-20-22771R2 Trends and predictors of in-hospital mortality among babies with hypoxic ischaemic encephalopathy at a tertiary hospital in Nigeria: a retrospective cohort study Dear Dr. Ezenwa: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ju Lee Oei Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .